{"id":"W4412765177","doi":"10.21037/hbsn-2025-250","title":"Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition","year":2025,"lang":"en","type":"letter","venue":"HepatoBiliary Surgery and Nutrition","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Empagliflozin; Disease; Diabetes mellitus; Intensive care medicine; Fatty liver; Type 2 diabetes; Bioinformatics; Pharmacology; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001062742,0.0005810399,0.0009839652,0.0004992794,0.001637042,0.00216495,0.0005571917,0.01710298,0.00346861],"category_scores_gemma":[0.007290651,0.0002802206,0.000995717,0.0003762729,0.001312998,0.001996498,0.0007785714,0.01635919,0.002192623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002432086,"about_ca_system_score_gemma":0.002107528,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002484015,"about_ca_topic_score_gemma":0.005885818,"domain_scores_codex":[0.9993248,0.0001908663,0.0000969684,0.00006285068,0.0002039493,0.0001206277],"domain_scores_gemma":[0.9984065,0.000754141,0.0001210371,0.00003818319,0.0002116579,0.0004685534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004481643,0.0002170167,0.002409721,0.0001375232,0.00004268384,0.01581982,0.0001100129,0.0002628977,0.0005051139,0.006384459,0.923343,0.05031971],"study_design_scores_gemma":[0.001107806,0.000564826,0.003646693,0.000806319,0.00008933666,0.01803828,0.0003514577,0.002150674,0.0004926795,0.02181486,0.9508616,0.0000753809],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.001675962,0.003228236,0.0002226645,0.966103,0.02183958,0.00002683789,0.00005450195,0.00002906133,0.006820086],"genre_scores_gemma":[0.01497105,0.005172235,0.000862083,0.8571514,0.1080749,0.00007500587,0.00008502538,0.0000232104,0.01358511],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01710298,"threshold_uncertainty_score":0.01764613,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02326468354255267,"score_gpt":0.2410515717774022,"score_spread":0.2177868882348495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}